In this eye-opening episode, John Sbrocco sits down with Justin Jasniewski, CEO of Serve You RX, to expose the hidden tricks and misaligned incentives within the PBM industry. They reveal why the introduction of Humira biosimilars failed to lower costs and how PBMs use tactics like “product hopping” to keep employers paying top dollar for specialty drugs.